You are here: Industry Insights > CNBG

News List

Pasaca Capital, Inc. with its portfolio company Innova Medical Group Establish Joint Venture with Sinopharm Group to Improve Access to COVID-19 Vaccines FirstWordPharma
November 12, 2021
Pasaca Capital Inc, the private equity firm that owns one of the worlds largest COVID-19 test providers, Innova Medical Group, Inc., and Sinopharm's China National Biotech Group (CNBG)...
Sinopharm executive suggests vaccinated people accept booster shots after China builds herd immunity firstwordpharma
August 24, 2021
Zhang Yuntao, chief scientist of Sinopharm's subsidiary China National Biotec Group (CNBG), suggested that vaccinated people in China could choose to accept booster shots when available after herd immunity is built in the country, Global Times reported.
China grants conditional market approval for Sinopharm CNBG's COVID-19 vaccine worldpharmanews
January 06, 2021
The inactivated COVID-19 vaccine developed by Beijing Institute of Biological Products of Sinopharm CNBG has been granted conditional registration by the NMPA of China, Chinese equivalent of FDA, according to a press conference of the ...
Sinovac’s COVID-19 vaccine candidate get emergency use approval in China expresspharma
August 31, 2020
Sinovac Biotech’s coronavirus vaccine candidate CoronaVac was approved for emergency use as part of a programme in China to vaccinate high-risk groups such as medical staff, a person familiar with the matter said.
World’s first phase III clinical trial of COVID-19 inactivated vaccine begins in UAE expresspharma
July 17, 2020
H.E. Sheikh Abdullah bin Mohammed Al Hamed, Chairman of Department of Health, Abu Dhabi is the first to participate in the vaccination trial.
Chinese firm says coronavirus vaccine candidate shows promise in human test expresspharma
June 30, 2020
The experimental shot, developed by a Beijing-based unit of CNBG, has induced high-level antibodies in all the inoculated participants in a Phase 1/2 clinical trial involving 1,120 healthy people.